MPs have asked what the break clause was for as Palantir won a second two-year extension to its NHS contract, with ministers promising fresh procurement but critics warning the extension gives the US supplier more time to dig in.
The contract, which runs to 2028, has been the subject of extended scrutiny in Parliament, with members asking pointed questions about the terms and the future of the UK’s public services’ reliance on a single technology supplier. The extension was approved despite concerns from opposition MPs and some health experts who argued that the UK should be moving towards a more diversified approach to procuring health technology, rather than investing more in a provider that has been criticised for its links to the Israeli government’s data practices in the occupied territories.
Ministers have promised to review the procurement process and to ensure that future contracts are awarded through a more transparent and competitive system. They said the extension was necessary to maintain the services that Palantir provides, and that the contractor has a good track record of delivering on its commitments. The promotion has described the relationship as a partnership, not a vendor lock-in, and said the government is committed to ensuring the best value for money for patients.
The UK government’s relationship with US technology companies has long been a subject of debate, with concerns about data security, the influence of foreign firms on public services, and the balance between innovation and sovereignty. The NHS has been an early adopter of Palantir’s software, and the contract has been funded through a combination of central and local budgets. The government has said it is reviewing its approach to procurement and will consider whether the current arrangement represents value for money.
The contract matters because it is a symbol of a broader tension in UK technology policy: the desire to be at the cutting edge of innovation while protecting national security and ensuring that public money is spent wisely. The NHS is the largest employer in the UK, and its technology decisions have implications for millions of patients and for the country’s economic competitiveness.
Why it matters
The contract matters because it raises fundamental questions about how the UK’s public services should be supplied in an era of globalised technology markets. The government’s willingness to extend a contract with a single supplier, despite criticism from MPs, suggests that the procurement system is not as competitive or as transparent as it should be. The wider issue is whether the UK should continue to rely on a small number of US tech giants for critical public services, and what that means for national sovereignty and data security.
ADVERTISEMENT
What happens next
The government has promised to review the procurement process and to consider how future contracts are awarded. The new contract period will begin, and Palantir will continue to deliver its services. The opposition and health experts will continue to scrutinise the arrangement, and the public will be left to judge whether the extension represents value for money. The government has said it will publish more details about the contract in due course, and that it remains open to a more competitive approach to procurement in future.



























We do not allow links of any sort in comments. No SPAM whatsoever. On topic comments only.